Skip to main content

MEDANTA · Global Health Limited · Documents

1,453.55 INR +13.90 (+0.97%) At close · Nov 13
Volume · Nov 13 6880 Avg daily vol (3M) 48.61K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 4, 2026
2026
Nov 4
Earnings call
Q2 revenue rises 34%, operating EBITDA grows 60%

Global Health Limited reported Q2 FY27 revenue from operations of INR 14,690 million, up 34% year-on-year, and operating EBITDA of INR 3,701 million, up 60%, with a 25.2% margin. Noida reached EBITDA breakeven, while a 500-bed Ghaziabad hospital was approved.

5 source passages
Global Health Limited – Medanta Consolidated revenue from operations for the quarter was INR 14,690 million, representing a healthy growth of 34% year-on-year. Operating EBITDA grew 60% year-on-year to INR 3,701 million, with improved margins of 25.2% in Q2 FY27 compared to 21% in Q2 FY26. Medanta Noida achieved EBITDA breakeven in Q2 FY27, posting revenue from operations of INR 1,059 million and operating EBITDA of INR 86 million for the quarter. Let me now brief you on our new Ghaziabad hospital project. Yesterday, our Board has approved a 500-bed hospital project with a total capex of approximately INR 1,000 crores. Open the document at this passage
Showing 1–3 of 3 documents